Cargando…

SYMPOSIUM TOPIC: Changing paradigms in Substance Use Disorders

The understanding of epigenetics in Psychiatry has provided a change in paradigm in the etiology and management of substance use disorders (SUD). The discovery of epigenetic changes in SUD that is being translated into drugs to reverse these changes, will be discussed. Although SUDs are associated w...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129770/
http://dx.doi.org/10.4103/0019-5545.341815
_version_ 1784712836958650368
collection PubMed
description The understanding of epigenetics in Psychiatry has provided a change in paradigm in the etiology and management of substance use disorders (SUD). The discovery of epigenetic changes in SUD that is being translated into drugs to reverse these changes, will be discussed. Although SUDs are associated with high adolescent mortality and morbidity, less than 10% receive treatment. Management challenges including motivation and engagement, family involvement, focusing on social ecology and provision of follow up. A well structured de-addiction programme was unveiled at Deaddiction Centre at Barrackpore. Early results of such programme have been gratifying, and will be discussed, to look into future challenges and opportunities. Speaker 1: Epigenetics in SUD Col Anurag Timothy, 403 Fd Hosp Speaker 2: SUDs in adolescents Lt Col Bikram Kr Dutta, Base Hosp, Delhi Cantt Speaker 3: Management of SUDs at Deaddiction Centre Lt Col Rashmi Chakraborty, Base Hospital, Barrackpore
format Online
Article
Text
id pubmed-9129770
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-91297702022-05-25 SYMPOSIUM TOPIC: Changing paradigms in Substance Use Disorders Indian J Psychiatry Symposium Topic The understanding of epigenetics in Psychiatry has provided a change in paradigm in the etiology and management of substance use disorders (SUD). The discovery of epigenetic changes in SUD that is being translated into drugs to reverse these changes, will be discussed. Although SUDs are associated with high adolescent mortality and morbidity, less than 10% receive treatment. Management challenges including motivation and engagement, family involvement, focusing on social ecology and provision of follow up. A well structured de-addiction programme was unveiled at Deaddiction Centre at Barrackpore. Early results of such programme have been gratifying, and will be discussed, to look into future challenges and opportunities. Speaker 1: Epigenetics in SUD Col Anurag Timothy, 403 Fd Hosp Speaker 2: SUDs in adolescents Lt Col Bikram Kr Dutta, Base Hosp, Delhi Cantt Speaker 3: Management of SUDs at Deaddiction Centre Lt Col Rashmi Chakraborty, Base Hospital, Barrackpore Wolters Kluwer - Medknow 2022-03 2022-03-24 /pmc/articles/PMC9129770/ http://dx.doi.org/10.4103/0019-5545.341815 Text en Copyright: © 2022 Indian Journal of Psychiatry https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Symposium Topic
SYMPOSIUM TOPIC: Changing paradigms in Substance Use Disorders
title SYMPOSIUM TOPIC: Changing paradigms in Substance Use Disorders
title_full SYMPOSIUM TOPIC: Changing paradigms in Substance Use Disorders
title_fullStr SYMPOSIUM TOPIC: Changing paradigms in Substance Use Disorders
title_full_unstemmed SYMPOSIUM TOPIC: Changing paradigms in Substance Use Disorders
title_short SYMPOSIUM TOPIC: Changing paradigms in Substance Use Disorders
title_sort symposium topic: changing paradigms in substance use disorders
topic Symposium Topic
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129770/
http://dx.doi.org/10.4103/0019-5545.341815